发明申请
US20080194576A1 Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists
有权
嘧啶衍生物及其用作P2Y12受体拮抗剂
- 专利标题： Pyrimidine Derivatives and Their Use as P2Y12 Receptor Antagonists
- 专利标题（中）： 嘧啶衍生物及其用作P2Y12受体拮抗剂
-
申请号： US11912545申请日： 2006-04-27
-
公开(公告)号： US20080194576A1公开(公告)日： 2008-08-14
- 发明人: Eva Caroff , Kurt Hilpert , Olivier Houille , Francis Hubler , Emmanuel Meyer
- 申请人： Eva Caroff , Kurt Hilpert , Olivier Houille , Francis Hubler , Emmanuel Meyer
- 申请人地址： CH Allschwil
- 专利权人： ACTELION PHARMACEUTICALS LTD.
- 当前专利权人： ACTELION PHARMACEUTICALS LTD.
- 当前专利权人地址： CH Allschwil
- 优先权： EPPCT/EP2005/004578 20050428; IBPCT/IB2005/053711 20051110
- 国际申请： PCT/IB06/51318 WO 20060427
- 主分类号： A61K31/506
- IPC分类号： A61K31/506 ; C07D403/12 ; A61P9/10
摘要：
The invention relates to 4-aminocarbonyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention and/or treatment of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular and of cerebrovascular diseases or conditions associated with platelet aggregation, including thrombosis in humans and other mammals.
公开/授权文献
信息查询
IPC分类:
